How an Indian Government Policy Backfired: Prescription Drug Price Regulations Led to More Marketing for Unregulated Medications
A new Journal of Marketing study shows how India aimed to make essential medicines more affordable but inadvertently ended up reducing drug sales. Read an in-depth recap of this research here: https://www.ama.org/2024/06/04/how-an-indian-government-policy-backfired-prescription-drug-price-regulations-led-to-more-marketing-for-unregulated-medications/ Read the full Journal of Marketing article here: https://doi.org/10.1177/00222429241242685 Reference: Saravana Jaikumar, Pradeep K. Chintagunta, and Arvind Sahay, “Do No Harm? Unintended Consequences of Pharmaceutical Price Regulation in India,” Journal of Marketing. Narrator: Adalgisa Butkewitsch Acknowledgments: Sushma Kambagowni Topics: regulations, drug prices, healthcare marketing The JM Buzz Podcast is a production of the American Marketing Association's Journal of Marketing and is produced by University FM